Call for Abstracts

The regular abstract submission as well as the Late Breaker abstract submission are closed.

Thank you to all abstract submitters for their contribution.

All abstracts accepted for the conference will be presented as oral or poster presentations. They will be published in the abstract book (available for purchase during online registration) and on the abstract CD-ROM (available on site).

As an Affiliated Event of the 17th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV, co-submission of abstracts to the European AIDS Conference and to the 17th International Co-morbidities Workshop is permissible.

Abstract Submission Guidelines

- Fields marked with a red star are mandatory
- Abstracts must be submitted in English only
- The text should not exceed 300 words (excluding abstract title & authors)
- Abstracts sent by fax, post or e-mail will not be accepted

The text of the abstract should briefly state:
- Objectives (indicate the purpose of the study or the hypothesis that was tested)
- Methods (include the setting for the study, the subjects, the diagnosis or intervention and the type of statistical analysis; if references are needed, they should be given in the text)
- Results (present as clearly as possible the outcome of the study and statistical significance if appropriate)
- Conclusion (briefly discuss the data and emphasize the significance of the results)

Straight encore submissions without new data will not be accepted. Encores with
additional new data will be considered.

Tables and graphics can be included in the abstract. These will not add to the word count.

As long as the abstract is not submitted, it remains in "Draft" status, which means
modifications can be made until the abstract submission deadline.
Please do not forget to submit your abstract. Abstracts remaining in draft status will not be considered.
A confirmation of receipt will be sent via e-mail upon submission of an abstract. Presenting authors should register to the conference upon submitting their abstract.


The size of your poster should not exceed 120cm (height) and 80 cm (width) and have to be in portrait format. Posters should be printed on paper, portait format; posters printed on fabric will not be accepted.

Abstract Categories

1. Virology (incl. Molecular Virology, Diversity, excl. Resistance)
2. Immunology (incl. HIV-specific Immunity, Innate Immunity, Immune Reconstitution)
3. Pathogenesis and Immunopathogenesis
4. Human Genomics (incl. Pathogenesis, Genome Wide Association Studies, Clinical)
5. Vaccines and Immune Based Therapies (incl. Development, Preclinical and Clinical)
6. Antiretroviral Therapy – Preclinical
7. Antiretroviral – Randomized Clinical Trials
8. Antiretroviral – Observational Studies
9. HIV Drug Resistance (incl. Pathogenesis, Clinical and Epidemiological Aspects)
10. Pharmacology, Pharmacogenomics and Drug Interactions
11. Complications of Antiretroviral Therapy (incl. Pathogenesis of Toxicity, Clinical and Epidemiological Aspects)
12. Morbidity / Mortality in the Era of cART (incl. HIV and non HIV)
13. Viral Hepatitis (incl. Pathogenesis, Clinical, Therapeutic and Epidemiological Aspects)
14. Tuberculosis and Opportunistic Infections
15. Co-morbidities (incl. Metabolic Complications, Neuropathogenesis, Ageing)
16. HIV-Associated and non HIV-Associated Tumours
17. Other Co-infections / Sexually Transmitted Infections
18. Prevention of Horizontal Transmission, cART as Prevention (incl. PreP and PEP and Other Preventive Measures)
19. Mother-to-Child Transmission
20. Paediatric, Adolescent
21. Epidemiology (incl. HIV-Prevalence Incidence / Dynamics of the HIVEpidemic, Molecular Epidemiology)
22. Treatment in Resource-Constrained Settings
23. Social and Behavioural Science
24. Gender Issues

Should you have any questions, please contact:
EACS Conference Secretariat
c/o K.I.T. Group GmbH
Association & Conference Management
Kurfürstendamm 71
10709 Berlin - Germany
Phone: +49 30 24603-231
Fax: +49 30 24603-269